HF
TRAW icon

HRT Financial’s Traws Pharma TRAW Stock Holding History

HRT Financial’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76K Buy
+91,220
New +$126K ﹤0.01% 3680
2025
Q4 		– Sell
-12,573
Closed -$23K – 4214
2025
Q3 		$23K Buy
+12,573
New +$20.5K ﹤0.01% 2693
2021
Q2 		– Sell
-1,772
Closed -$663K – 3651
2021
Q1 		$663K Buy
1,772
+1,637
+1,213% +$617K 0.01% 1564
2020
Q4 		$23K Sell
135
-930
-87% -$108K ﹤0.01% 1741
2020
Q3 		$111K Buy
1,065
+1,019
+2,215% +$252K ﹤0.01% 1503
2020
Q2 		$9K Buy
+46
New +$7.03K ﹤0.01% 1474
2020
Q1 		– Sell
-61
Closed -$8K – 1438
2019
Q4 		$8K Buy
+61
New +$11.4K ﹤0.01% 1096

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

HRT Financial's TRAW Position: Q2 2026 in Review

HRT Financial opened a new position in Traws Pharma (TRAW) in Q2 2026: 91,220 shares worth $76K. The stake represents ﹤0.01% of the portfolio and ranks #3680 among its holdings. This is a return to the name: HRT Financial previously reported a position in TRAW as recently as Q3 2025.

HRT Financial first reported a position in TRAW in Q4 2019 and has held it in 7 quarters since. The position peaked at $663K in Q1 2021. 34 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • HRT Financial held 91,220 shares of Traws Pharma worth $76K as of Q2 2026.
  • Traws Pharma was a new HRT Financial position in Q2 2026.
  • Traws Pharma made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3680 holding.
  • HRT Financial first reported a position in Traws Pharma in Q4 2019 and has held it in 7 quarters since.
  • HRT Financial's Traws Pharma position peaked at $663K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.